Blog
News and insights about endometriosis research
Molecular Heterogeneity in Endometriosis: New Research from endogene.bio
France-based biotech endogene.bio has published research suggesting that endometriosis is molecularly heterogeneous across patients, lesion sites, and cell types.
Read more
Looking back at 2025: Long-Awaited, Meaningful Progress in Endometriosis Innovation
2025 nears a close, and whilst we all struggle to carve out quiet moments in the all-too-hectic holiday times, I increasingly find myself encouraged by where endometriosis research stands today—and where it’s potentially heading.
Read more
Innovative therapeutic approach: Migraine drugs show potential for treating endometriosis pain
A new study brings hope: migraine medications could not only relieve pain, but also reduce endometriosis lesions.
Read more
Another hope: Two new approaches to treating endometriosis discovered with the help of AI
A recent study used artificial intelligence to identify two new therapeutic targets and an already approved drug for the treatment of endometriosis.
Read more
New hope: Celmatix develops innovative JNK inhibitor therapy
New York-based biotechnology company Celmatix has announced a new drug development program aimed at treating endometriosis.
Read more
YOU too can make a difference!
Raising awareness of endometriosis is crucial to improving the lives of those affected. Here are some ways you can get involved.
Read more
Endo medications without hormones
The Swiss company FimmCyte is venturing into drug development. There are high hopes for a new drug that can stop endo lesions.
Read more